Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt

Abbott India

Market Cap: ₹698.8b

Operates as a pharmaceutical company in India.

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹523.3b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

Blue Jet Healthcare

Market Cap: ₹138.0b

Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.

Sanofi India

Market Cap: ₹133.3b

Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.

Procter & Gamble Health

Market Cap: ₹97.1b

Engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally.

Jeena Sikho Lifecare

Market Cap: ₹66.5b

Trades in ayurvedic medicines in India.

RPG Life Sciences

Market Cap: ₹41.2b

An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.

Ind-Swift Laboratories

Market Cap: ₹6.3b

Develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally.

Influx Healthtech

Market Cap: ₹3.7b

Operates as a contract development and manufacturing organization that provides a range of healthcare products in India.

Asston Pharmaceuticals

Market Cap: ₹1.0b

Engages in the manufacturing and selling of pharmaceutical formulations and nutraceutical products in India, West Africa, South Africa, and rest of Asia.

Genesis IBRC India

Market Cap: ₹369.2m

Does not have significant operations.